نتائج البحث - Mark Forrest-Gordon

Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson’s Disease حسب William Seiple, Danna Jennings, Richard B. Rosen, Leona Borchert, Lee Canale, Nora Fagan, Mark Forrest Gordon

احصل على النص الكامل

Minimal Clinically Important Difference in Parkinson’s Disease as Assessed in Pivotal Trials of Pramipexole Extended Release حسب Robert A. Hauser, Mark Forrest Gordon, Yoshikuni Mizuno, Werner Poewe, Paolo Barone, Anthony H. Schapira, Olivier Rascol, Catherine Debieuvre, Mandy Fräßdorf

احصل على النص الكامل

Is the association between blood pressure and cognition in the oldest-old modified by physical, vascular or brain pathology markers? The EMIF-AD 90 + Study حسب Nienke Legdeur, Justine E. Moonen, Maryam Badissi, Carole H. Sudre, Wiesje Pelkmans, Mark Forrest Gordon, Frederik Barkhof, Mike Peters, Pieter Jelle Visser, Majon Muller

احصل على النص الكامل

Vascular and metabolic risk factor differences prior to dementia diagnosis: a multidatabase case–control study using European electronic health records حسب Johan van Der Lei, Robert Stewart, Pieter Jelle Visser, Talita Duarte-Salles, Myriam Alexander, David Ansell, Alessandro Pasqua, Francesco Lapi, Paul Avillach, Lars Pedersen, Gayan Perera, Mark Forrest Gordon, Miguel Angel Mayer

احصل على النص الكامل

Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease حسب Samuel Frank, Karen E. Anderson, Hubert H. Fernandez, Robert A. Hauser, Daniel O. Claassen, David Stamler, Stewart A. Factor, Joohi Jimenez-Shahed, Hadas Barkay, Amanda Wilhelm, Jessica K. Alexander, Nayla Chaijale, Steve Barash, Juha-Matti Savola, Mark Forrest Gordon, Maria Chen

احصل على النص الكامل

Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease حسب Samuel Frank, Karen E. Anderson, Hubert H. Fernandez, Robert A. Hauser, Daniel O. Claassen, David Stamler, Stewart A. Factor, Joohi Jimenez-Shahed, Hadas Barkay, Amanda Wilhelm, Jessica K. Alexander, Nayla Chaijale, Steve Barash, Juha-Matti Savola, Mark Forrest Gordon, Maria Chen

احصل على النص الكامل

The future of clinical trials? Monitoring mobility as an outcome measure in Parkinson's disease: The mobilise-D study حسب Alison J Yarnall, Lisa Alcock, Christian Schlenstedt, Claudia Armengol, Clemens Becker, Philip Brown, Joren Buekers, Brian Caulfield, Andrea Cereatti, Laura Cordova-Rivera, Silvia Del Din, Laura Delgado-Ortiz, Mark Forrest-Gordon, Judith Garcia-Aymeriche, Pia Goerrissen, Clint Hansen, Hanna Hildesheim, Hugo Hiden, Heather Hunter, Carl-Philipp Jansen, Sarah Koch, Jennifer Kudelka, Michael Long, Isabel Neatrour, Basil Sharrack, David Singleton, Lou Sutcliffe, Thierry Troosters, Juergen Winkler, Pieter Ginis, Heiko Gassner, Alice Nieuwboer, Jeffrey M Hausdorff, Anat Mirelman, Lynn Rochester, Walter Maetzler

احصل على النص الكامل

Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocol. حسب A Stefanie Mikolaizak, Lynn Rochester, Walter Maetzler, Basil Sharrack, Heleen Demeyer, Claudia Mazzà, Brian Caulfield, Judith Garcia-Aymerich, Beatrix Vereijken, Valdo Arnera, Ram Miller, Paolo Piraino, Nadir Ammour, Mark Forrest Gordon, Thierry Troosters, Alison J Yarnall, Lisa Alcock, Heiko Gaßner, Jürgen Winkler, Jochen Klucken, Christian Schlenstedt, Henrik Watz, Anne-Marie Kirsten, Ioannis Vogiatzis, Nikolaos Chynkiamis, Emily Hume, Dimitrios Megaritis, Alice Nieuwboer, Pieter Ginis, Ellen Buckley, Gavin Brittain, Giancarlo Comi, Letizia Leocani, Jorunn L Helbostad, Lars Gunnar Johnsen, Kristin Taraldsen, Hubert Blain, Valérie Driss, Anja Frei, Milo A Puhan, Ashley Polhemus, Magda Bosch de Basea, Elena Gimeno, Nicholas S Hopkinson, Sara C Buttery, Jeffrey M Hausdorff, Anat Mirelman, Jordi Evers, Isabel Neatrour, David Singleton, Lars Schwickert, Clemens Becker, Carl-Philipp Jansen, clinical validation study (WP4) on behalf of Mobilise-D consortium

احصل على النص الكامل